Obesity and the Risk for a Hematological Malignancy: Leukemia, Lymphoma, or Myeloma

Oncologist - Tập 15 Số 10 - Trang 1083-1101 - 2010
Marshall A. Lichtman1
1University of Rochester Medical Center, Rochester, New York, USA

Tóm tắt

Abstract The aggregate of epidemiological studies indicates a significantly elevated risk for cancer in people with a high body mass index (BMI); a “dose–response” effect exists with increasing risk as BMI increases from the normal to overweight to obese categories. Successful sustained weight loss decreases future risk. The relationship of being overweight to the risk for leukemia in the aggregate has been supported in several large cohort studies and two meta-analyses of cohort and case–control studies. One meta-analysis found an elevated risk for each of the four major subtypes of leukemia. A significant association between the risk for non-Hodgkin's lymphoma and elevated BMI was supported by a meta-analysis of 13 cohort and nine case–control studies. The risk for diffuse large B-cell lymphoma may be especially significant. A high BMI increases the risk for myeloma, as judged by a meta-analysis of 11 cohort and four case–control studies. The biological relationship of obesity to the risk for cancer (biological plausibility) is unresolved. The two major causal final pathways could be “inductive” or “selective.” The metabolic, endocrinologic, immunologic, and inflammatory-like changes resulting from obesity may increase the cell mutation rate, dysregulate gene function, disturb DNA repair, or induce epigenetic changes, favoring the induction of neoplastic transformation (inductive). Alternatively, obesity may create an environment in which pre-existing clones that are dormant are permitted (selected) to emerge.

Từ khóa


Tài liệu tham khảo

Centers for Disease Control and Prevention, Overweight and Obesity

Flegal, 2010, Prevalence and trends in obesity among US adults, 1999–2008, JAMA, 303, 235, 10.1001/jama.2009.2014

Roberts, 2010, Biological mechanisms linking obesity and cancer risk: New perspectives, Annu Rev Med, 61, 301, 10.1146/annurev.med.080708.082713

Wolin, 2010, Obesity and cancer, The Oncologist, 15, 556, 10.1634/theoncologist.2009-0285

Calle, 2003, Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults, N Engl J Med, 348, 1625, 10.1056/NEJMoa021423

Samanic, 2004, Obesity and cancer risk among white and black United States veterans, Cancer Causes Control, 15, 35, 10.1023/B:CACO.0000016573.79453.ba

Pan, 2004, Canadian Cancer Registries Epidemiology Research Group. Association of obesity and cancer risk in Canada, Am J Epidemiol, 159, 259, 10.1093/aje/kwh041

Reeves, 2007, Million Women Study Collaboration. Cancer incidence and mortality in relation to body mass index in the Million Women Study: Cohort study, BMJ, 335, 1134, 10.1136/bmj.39367.495995.AE

Oh, 2005, Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation Study, J Clin Oncol, 23, 4742, 10.1200/JCO.2005.11.726

Renehan, 2008, Body-mass index and incidence of cancer: A systematic review and meta-analysis of prospective observational studies, Lancet, 371, 569, 10.1016/S0140-6736(08)60269-X

Söderberg, 2009, Overweight, obesity and risk of haematological malignancies: A cohort study of Swedish and Finnish twins, Eur J Cancer, 45, 1232, 10.1016/j.ejca.2008.11.004

Renehan, 2010, Incident cancer burden attributable to excess body mass index in 30 European countries, Int J Cancer, 126, 692, 10.1002/ijc.24803

Ml̸ler, 1994, Obesity and cancer risk: A Danish record-linkage study, Eur J Cancer, 30A, 344, 10.1016/0959-8049(94)90254-2

Engeland, 2007, Height and body mass index and risk of lymphohematopoietic malignancies in two million Norwegian men and women, Am J Epidemiol, 165, 44, 10.1093/aje/kwj353

Fernberg, 2007, Tobacco use, body mass index, and the risk of leukemia and multiple myeloma: A nationwide cohort study in Sweden, Cancer Res, 67, 5983, 10.1158/0008-5472.CAN-07-0274

MacInnis, 2005, Body size and composition and the risk of lymphohematopoietic malignancies, J Natl Cancer Inst, 97, 1154, 10.1093/jnci/dji209

Larsson, 2008, Overweight and obesity and incidence of leukemia: A meta-analysis of cohort studies, Int J Cancer, 122, 1418, 10.1002/ijc.23176

Kasim, 2005, Lifestyle factors and the risk of adult leukemia in Canada, Cancer Causes Control, 16, 489, 10.1007/s10552-004-7115-1

Ross, 2004, Body mass index and risk of leukemia in older women, Cancer Epidemiol Biomarkers Prev, 13, 1810, 10.1158/1055-9965.EPI-03-2135

Estey, 1997, Association between increased body mass index and a diagnosis of acute promyelocytic leukemia in patients with acute myeloid leukemia, Leukemia, 11, 1661, 10.1038/sj.leu.2400783

Wong, 2009, A hospital-based case-control study of acute myeloid leukemia in Shanghai: Analysis of personal characteristics, lifestyle and environmental risk factors by subtypes of the WHO classification, Regul Toxicol Pharmacol, 55, 340, 10.1016/j.yrtph.2009.08.007

Jeddi, 2010, High body mass index is an independent predictor of differentiation syndrome in patients with acute promyelocytic leukemia, Leuk Res, 34, 545, 10.1016/j.leukres.2009.09.017

Konopleva, 1999, Expression and function of leptin receptor isoforms in myeloid leukemia and myelodysplastic syndromes: Proliferative and anti-apoptotic activities, Blood, 93, 1668, 10.1182/blood.V93.5.1668.405a15_1668_1676

Considine, 1997, Leptin and the regulation of body weight, Int J Biochem Cell Biol, 29, 1255, 10.1016/S1357-2725(97)00050-2

Gainsford, 1996, Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells, Proc Natl Acad Sci U S A, 93, 14564, 10.1073/pnas.93.25.14564

Strom, 2009, Obesity, weight gain, and risk of chronic myeloid leukemia, Cancer Epidemiol Biomarkers Prev, 18, 1501, 10.1158/1055-9965.EPI-09-0028

Willett, 2006, Obesity and the risk of Hodgkin lymphoma (United Kingdom), Cancer Causes Control, 17, 1103, 10.1007/s10552-006-0042-6

Paffenbarger, 1977, Characteristics in youth indicative of adult-onset Hodgkin's disease, J Natl Cancer Inst, 58, 1489, 10.1093/jnci/58.5.1489

Pan, 2005, Canadian Cancer Registries Epidemiology Research Group. Physical activity, obesity, energy intake, and the risk of non-Hodgkin's lymphoma: A population-based case-control study, Am J Epidemiol, 162, 1162, 10.1093/aje/kwi342

Wolk, 2001, A prospective study of obesity and cancer risk (Sweden), Cancer Causes Control, 12, 13, 10.1023/A:1008995217664

Cerhan, 2005, Anthropometrics, physical activity, related medical conditions, and the risk of non-Hodgkin lymphoma, Cancer Causes Control, 16, 1203, 10.1007/s10552-005-0358-7

Chiu, 2006, Body mass index, abnormal glucose metabolism, and mortality from hematopoietic cancer, Cancer Epidemiol Biomarkers Prev, 15, 2348, 10.1158/1055-9965.EPI-06-0007

Chang, 2005, Body mass index and risk of malignant lymphoma in Scandinavian men and women, J Natl Cancer Inst, 97, 210, 10.1093/jnci/dji012

Bosetti, 2005, Re: Body mass index and risk of malignant lymphoma in Scandinavian men and women [letter], J Nat Cancer Inst, 97, 860, 10.1093/jnci/dji150

Dal Maso, 2004, Hepatitis B and C viruses and Hodgkin lymphoma: A case-control study from Northern and Southern Italy, Haematologica, 89, ELT17

Chiu, 2007, Obesity and risk of non-Hodgkin lymphoma (United States), Cancer Causes Control, 18, 677, 10.1007/s10552-007-9013-9

Skibola, 2007, Obesity, diet and risk of non-Hodgkin lymphoma, Cancer Epidemiol Biomarkers Prev, 16, 392, 10.1158/1055-9965.EPI-06-1081

Maskarinec, 2008, Overweight and obesity at different times in life as risk factors for non-Hodgkin's lymphoma: The multiethnic cohort, Cancer Epidemiol Biomarkers Prev, 17, 196, 10.1158/1055-9965.EPI-07-0716

Morton, 2008, Etiological heterogeneity among non-Hodgkin lymphoma subtypes, Blood, 112, 5150, 10.1182/blood-2008-01-133587

Willett, 2008, InterLymph Consortium. Non-Hodgkin lymphoma and obesity: A pooled analysis from the InterLymph Consortium, Int J Cancer, 122, 2062, 10.1002/ijc.23344

Pylypchuk, 2009, Body mass index, height, and risk of lymphatic malignancies: A prospective cohort study, Am J Epidemiol, 170, 297, 10.1093/aje/kwp123

Willett, 2005, Non-Hodgkin's lymphoma, obesity and energy homeostasis polymorphisms, Br J Cancer, 93, 811, 10.1038/sj.bjc.6602762

Larsson, 2007, Obesity and risk of non-Hodgkin's lymphoma: A meta-analysis, Int J Cancer, 121, 1564, 10.1002/ijc.22762

Troy, 2010, Associations between anthropometry, cigarette smoking, alcohol consumption, and non-Hodgkin lymphoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial, Am J Epidemiol, 171, 1270, 10.1093/aje/kwq085

Friedman, 1994, Obesity and multiple myeloma, Cancer Causes Control, 5, 479, 10.1007/BF01694762

Khan, 2006, JACC Study Group. Risk factors for multiple myeloma: Evidence from the Japan Collaborative Cohort (JACC) study, Asian Pac J Cancer Prev, 7, 575

Brown, 2001, Diet and nutrition as risk factors for multiple myeloma among blacks and whites in the United States, Cancer Causes Control, 12, 117, 10.1023/A:1008937901586

Blair, 2005, Anthropometric characteristics and risk of multiple myeloma, Epidemiology, 16, 691, 10.1097/01.ede.0000172135.61188.2d

Cozen, 2006, Interleukin-6-related genotypes, body mass index, and risk of multiple myeloma and plasmacytoma, Cancer Epidemiol Biomarkers Prev, 15, 2285, 10.1158/1055-9965.EPI-06-0446

Birmann, 2007, Body mass index, physical activity, and risk of multiple myeloma, Cancer Epidemiol Biomarkers Prev, 16, 1474, 10.1158/1055-9965.EPI-07-0143

Larsson, 2007, Body mass index and risk of multiple myeloma: A meta-analysis, Int J Cancer, 121, 2512, 10.1002/ijc.22968

Landgren, 2010, Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women, Blood, 116, 1056, 10.1182/blood-2010-01-262394

Lichtman, 2008, Battling the hematological malignancies: The 200 years' war, The Oncologist, 13, 126, 10.1634/theoncologist.2007-0228

Lichtman, 2007, Cigarette smoking, cytogenetic abnormalities, and acute myelogenous leukemia, Leukemia, 21, 1137, 10.1038/sj.leu.2404698

Lichtman, 1967, The distribution of serum immunoglobulins, anti-gamma-G globulins (“rheumatoid factors”) and antinuclear antibodies in White and Negro subjects in Evans County, Georgia, Arthritis Rheum, 10, 204, 10.1002/art.1780100306

Sjöström, 2009, Swedish Obese Subjects Study. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): A prospective, controlled intervention trial, Lancet Oncol, 10, 653, 10.1016/S1470-2045(09)70159-7

Wolin, 2008, Can weight loss prevent cancer?, Br J Cancer, 99, 995, 10.1038/sj.bjc.6604623

Bray, 2004, Medical consequences of obesity, J Clin Endocrinol Metab, 89, 2583, 10.1210/jc.2004-0535

Key, 2010, Symposium 1. Overnutrition: Consequences and solutions. Obesity and cancer risk, Proc Nutr Soc, 69, 86, 10.1017/S0029665109991698

Hursting, 2008, Reducing the weight of cancer: Mechanistic targets for breaking the obesity-carcinogenesis link, Best Pract Res Clin Endocrinol Metab, 22, 659, 10.1016/j.beem.2008.08.009

Becker, 2009, Obesity related hyperinsulinaemia and hyperglycaemia and cancer development, Arch Physiol Biochem, 115, 86, 10.1080/13813450902878054

Dalamaga, 2009, Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: A case-control study, Cancer Causes Control, 20, 193, 10.1007/s10552-008-9233-7

Bray, 2002, The underlying basis for obesity: Relationship to cancer, J Nutr, 132, 3451S, 10.1093/jn/132.11.3451S

Thông tin
Thông tin xuất bản

Oncologist

Tập 15 Số 10

1083-1101

Thông tin tác giả